
|KL14| Male oncological examination package
89.00€
The validity period of online orders: 3 months from the purchase date.
Research Comparison
Hematological and Clinical Tests | Men's Oncological Examination Program |
CBC | Complete Blood Count | |
ESR | Erythrocyte Sedimentation Rate |
Inflammatory marker tests | Men's oncological examination program |
CRP | C-reactive protein |
Cancer Marker Tests | Male Oncological Examination Program |
AFP | Alpha-fetoprotein (Testicular Cancer Marker) | |
CEA | Carcinoembryonic Antigen | |
CA-19-9 | Pancreatic Cancer Marker | |
CA-72-4 | Gastric Cancer Marker | |
PSA | Prostate-Specific Antigen | |
Description
The male oncology blood test package is an important tool for early cancer detection and condition monitoring. These tests are particularly significant as they can help identify the disease at an early stage when treatment options and survival predictions are most favorable.
Who should consider and benefit from undertaking these tests?
These tests are particularly beneficial for men who:
- Have a family history of cancer cases, especially among direct relatives, which increases cancer risk.
- Reached a certain age when cancer risk increases, especially men over 50 years old due to prostate cancer.
- Notice symptoms that may signal an oncological condition, such as unexplained weight loss, persistent cough, unusual skin changes, liver function disorders, or worsened digestive problems.
When is it recommended to perform these tests?
It is recommended to perform the tests:
- Regularly, as part of older men's health check-up, especially if they belong to higher risk groups.
- In the presence of any new or unusual symptoms that may be related to cancer.
- After cancer treatment, monitoring disease remission or detecting possible recurrence.
What can the patient learn after undergoing these tests?
After undergoing these tests, the patient can learn:
- General health condition through a complete blood test, which can reveal anemia or inflammatory processes.
- Inflammatory and cancer markers, such as C-reactive protein, erythrocyte sedimentation rate, carcinoembryonic antigen (CEA), and specific organ cancer markers (e.g., PSA for prostate cancer, CA-19-9 for gastrointestinal cancers, CA-72-4 for stomach cancer, AFP for liver cancer).
- Important information about the possible presence or absence of cancer, which helps decide on further diagnostic and treatment actions.
These tests are indispensable tools for men who want to proactively take care of their health and prevent the spread of cancer or detect it early when the chances of treatment are best.